Changes in determinants of blood rheology during treatment with haemodialysis and recombinant human erythropoietin.
Koppensteiner
R
R
First Department of Medicine, University of Vienna, Austria.
Stockenhuber
F
F
Jahn
C
C
Balcke
P
P
Minar
E
E
Ehringer
H
H
D000328:Adult; D000368:Aged; D000740:Anemia / Q000097:blood* / Q000188:drug therapy; D001809:Blood Viscosity / Q000187:drug effects*; D004903:Erythrocyte Aggregation / Q000187:drug effects*; D004921:Erythropoietin / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D005340:Fibrinogen / Q000032:analysis*; D006400:Hematocrit; D006801:Humans; D006973:Hypertension / Q000209:etiology; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use; D006435:Renal Dialysis / Q000009:adverse effects; D012212:Rheology; D013927:Thrombosis / Q000209:etiology
D011994:Recombinant Proteins; D004921:Erythropoietin; D005340:Fibrinogen